The official site of «SAM Pharmaceuticals Ltd»
Our company Competence Contact Us News
Home Contacts Print
What’s new
16.10.2018
01.10.2018
12.09.2018
Subscribe to news
Representation of companies in Russia
+7 (916) 367— 6534

The specialists of the Tomsk Institute of Cardiology, Tomsk Polytechnic University and the Novosibirsk company "Angioline" develop hybrid nanoparticles and vascular stent with a biodegradable coating for the treatment of atherosclerosis


Researchers have developed a technology for producing bioactive carbon nanoparticles that exhibit antagonistic properties with respect to the structure of an atherosclerotic plaque. The nanoparticles are capable to penetrate into the plaque and change its structure. Currently, there is created a vascular stent with a biodegradable coating comprising the nanomaterial. The product can enter the market in 2017. There are 50-60 thousand stents’ implantations in Russia every year in the real needs of 600 thousand.

← back